Related Topics
Why Public Health? Darrell Gray, II
May 2014 — In our video series “Why Public Health?” we ask Harvard T.H. Chan School of Public Health students and alumni to talk about what drew them to the field. Darrell Gray, II, MD, MPH ’14, is determined…
New molecule links asthma, cancer
A newly discovered molecule may play a role in controlling both asthma-induced airway muscle thickening and tumor growth—and manipulating it may lead to new asthma and cancer drugs, according to a new study led by researchers at Harvard…
Affordable cancer treatments are few, lack research funding
Research is lacking on potential low-cost cancer treatments because the drugs involved won’t provide big profits for pharmaceutical companies, according to an April 23, 2014 ProPublica article. The article describes the experience of Michael Retsky of Harvard School of…
Masculine boys, feminine girls more likely to engage in cancer risk behaviors
For immediate release: April 16, 2014 Boston, MA — Young people who conform most strongly to norms of masculinity and femininity—the most “feminine” girls and the most “masculine” boys—are significantly more likely than their peers to engage in…
K. ‘Vish’ Viswanath honored for tobacco control research, mentoring
K. “Vish” Viswanath, professor of health communications at Harvard School of Public Health (HSPH), recently was awarded two national honors. He received the Joseph W. Cullen Award for distinguished achievement in national tobacco control research and advocacy at…
Cancer prevention: Flexible work environment, folate supplementation may be protective
A flexible work environment that enables staff to make time for physical activity appears to reduce cancer risk in middle-aged workers, according to researchers at the Harvard School of Public Health (HSPH) Center for Work, Health, and Well-being.…
Prostate cancer: surgery vs. watchful waiting
For immediate release: Wednesday, March 5, 2014 Boston, MA -- More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate.…
Prostate cancer: Clearing up confusion
February 19, 2014 — Lorelei Mucci, associate professor of epidemiology at Harvard School of Public Health (HSPH), studies the factors that influence prostate cancer risk and progression. She answers three questions about recent research findings in the field…
Cancer a daunting challenge for poor countries
More than half of new cancer cases occur in low- and middle-income countries, as do nearly two-thirds of cancer deaths. Experts at a global oncology symposium held February 8, 2014 at Dana-Farber Cancer Institute discussed the substantial barriers…
Value of mammography questioned in large new study
A large new study suggests that mammograms may not save more women’s lives than physical breast exams alone, and in fact may lead to unnecessary treatment of small breast cancers that would likely pose no harm. The Canadian…